Navigation Links
Climatic variations influence the emergence of cholera in Africa
Date:9/5/2007

In studies aiming to understand better the emergence and persistence of cholera in Africa, IRD and CNRS researchers showed the strong correlation that exists between outbreaks and the different parameters linked to climate changes in West Africa. This research (1) should provide the scientists with the basis for creating a predictive model which could improve early warning of risks by anticipating the emergence of foci of infection and therefore facilitate the deployment of protection measures for the populations affected.

Cholera is an infectious disease caused by a bacterium, the bacillus Vibrio cholerae. In 2004, 101 383 cases, including 95 000 solely for the African continent, and 2 345 deaths were reported to the World Health Organization. Global climate change has for several years been contributing greatly to the spread of cholera through associated increase in the frequency of torrential rain, floods and periods of drought. It is now established that the spread of zooplankton which harbours the Vibrio cholerae bacterium follows that of phytoplankton, whose growth is directly related to climate variations. However, a host of factors act on the climatic conditions and they are difficult to study. Certain parameters vary depending on the regions of the world whereas others act on the global scale. The interactions between the climate and emergence of cholera must therefore be studied region by region. Research has been ongoing in Bangladesh and also in South America for many years, but up to now few studies have been conducted in Africa. Yet it is on that continent that the public health situation is giving the most cause for concern.

A study published by research scientists of the Laboratoire de Gn tique et Evolution des Maladies Infectieuses (GEMI), mixed research unit IRD/CNRS (2), is the first to yield evidence of the correlations between the outbreak of cholera epidemics and climatic data in 5 West African countries (Togo, Ivory Coast, Ghana, Benin and Nigeria). The research team set up an epidemiological database founded on cases recorded by the WHO over a 20-year period, between 1975 and 1995, in each of these countries. Comparison of these figures with parameters of local and global climate variations showed the factors particularly involved to be the volume of rainfall and the Indian Oscillation Index (IOI), an indicator of the global climate variability constructed from variations in atmospheric pressure in the Indian Ocean. Values of this index lower than 1 showed an association with a warm event such as an increase in sea surface temperature. In contrast, values above +1 coincided with cold events.

The annual rainfall regime and the IOI act on the aquatic environment in which Vibrio cholerae develops (estuaries, sea shores, river beds and so on). In the wild, the cholera bacillus lives in contact with small aquatic crustaceans, copepods, are a component of the zooplankton. These microscopic animals, which constitute the principal reservoir of the bacterium, feed on phytoplankton. They therefore have a tendency to congregate in the zones where the density of microscopic algae is highest. This relationship is fundamentally important. It provides a means to monitor the areas rich in plankton by remote sensing, and therefore to detect from space the potential reservoirs for Vibrio around the coasts.

Outbreaks of cholera appear irregular and, in order better to understand the epidemic pattern dynamics, the GEMI researchers used an adapted statistical tool that favours a wavelet analysis method. This novel process allows comparison of the frequencies of epidemic outbreaks with a range of climatic or environmental parameters (climate variability index, volume of precipitation, phytoplankton concentration near the coasts). This approach also takes into account the random variation of frequencies of emergence of epidemic foci.

The research team thus successfully linked the number of new cases of cholera first to the global climate variability index and then to monthly rainfall readings between 1989 and 1994. For that period, a frequency of epidemic occurrence of 2 to 3 years was indicated for the countries studied, except for the Ivory Coast. A significant correlation was also observed between the IOI and the annual rainfall regime for these same four countries. Furthermore, analysis of the interannual variability of rainfall between 1975 and 1996 indicated the existence of a 3 to 5year long cycle in the appearance of the disease for the whole of the areas covered by the study. The IOI and volume of precipitation are therefore two climatic variables that appear to be strongly correlated with the appearance of epidemic foci of cholera. The latter usually develop during seasonal periods but their rhythm period can also exceed the annual cycle (between 2 to 5 years). In other words, indirect relationships between climatic variations or variations in rainfall volume and emergence of foci of infection can persist for several years. These results agree with those obtained previously in Bangladesh and South America.

Over the coming years, the results of this research work should contribute to the creation of an early warning system that takes climatic parameters into account for prediction of cholera epidemic dynamics. That should facilitate the organization of prevention actions, such as drinking water filtration schemes, and the planning of care provision for people by supplying medical kits and rehydration kits. This kind of approach could also be applied to the understanding and prevention of other climate-sensitive illnesses such as malaria, dengue and other vector-borne diseases.


'/>"/>

Contact: Gregory Flechet
fichesactu@paris.ird.fr
33-014-803-7607
Institut de Recherche Pour le Dveloppement
Source:Eurekalert

Related medicine news :

1. Climatic Change Cause of Dafur Conflict-UN
2. Variations In ingredients From Brand to Brand
3. Gene Variations Raise the Risk of Childhood Cancer Survivors
4. Genetic Variations In Detoxifying Genes Lead To Lou Gehrigs diseases
5. Food Costs At Hospitals Show Mystifying Variations
6. Stroke Risk Higher with Gene Variations
7. Ethnic Variations in Hormone Levels May Cause Differences in Breast Cancer Risk
8. Large Variations in Cost Has No Effect on Length of Stay or Mortality
9. Genetic Variations Associated With Risk of Venous Thrombosis Identified
10. Variations of Post–Heart Attack Depression Affect Recover
11. Cataloging the Structural Variations in Human Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: